Results 121 to 130 of about 7,789 (204)

Comparative Effectiveness and Safety of Upadacitinib and Vedolizumab in Biologic‐Experienced Patients With Ulcerative Colitis: A Retrospective Study [PDF]

Neta Sror, Haim Leibovitzh, Ayal Hirsch, Tamar Thurm, Yulia Ron, Nitsan Maharshak, Nathaniel A. Cohen   +6 more
openalex   +1 more source

Alopecia Areata - Effects of Treatment with Upadacitinib - Two Case Reports. [PDF]

Clin Cosmet Investig Dermatol
Młyńska J, Mysiorska D, Zdanowska N, Owczarczyk-Saczonek A.   +3 more
europepmc   +1 more source

PO:02:016 | Real-world evidence of upadacitinib over two years in Italian patients with axial spondyloarthritis

Società Italiana Di Reumatologia
openalex   +3 more sources

Successful treatment of severe retroauricular pyoderma gangrenosum with upadacitinib in a patient with Crohn's disease and a history of cerebral venous sinus thrombosis. [PDF]

Ther Adv Gastroenterol
Fousekis F, Ronicke M, Sollfrank L, Rech J, Berking C, Neurath MF, Sticherling M, Atreya R.   +7 more
europepmc   +1 more source

Upadacitinib Reduces Crohn’s Disease Symptoms Within the First Week of Induction Therapy

Jean‐Frédéric Colombel, Tadakazu Hisamatsu, Raja Atreya, Francesca Bresso, Lena Thin, Remo Panaccione, Rogério Serafim Parra, Sharanya Ford, Valencia P. Remple, Ana Paula Lacerda, Samuel I. Anyanwu, Madhuja Mallick, Andrew Garrison, Miguel Regueiro   +13 more
openalex   +1 more source

Upadacitinib for the management of overlapping psoriasis and atopic dermatitis: a case series [PDF]

Carlos Calvo‐Asín, Fátima Tous‐Romero, Carmen García‐Donoso, Jose Puig‐Buendia, González‐Rodríguez Borja, Raquel Cavestany‐Rodríguez, Raquel Rivera‐Díaz   +6 more
openalex   +1 more source

Development of tinea corporis in a Japanese patient with atopic dermatitis under treatment with upadacitinib in a real‐world clinical setting: Possible contribution of the suppression of Th17

, 2022
Akihiko Uchiyama, Sei‐ichiro Motegi
openalex   +1 more source

Review of Herpes Zoster Occurrence in Patients With Atopic Dermatitis Treated With JAK Inhibitors. [PDF]

Clin Transl Sci
Mandecka A, Perlak K, Bajek W, Kruczek W, Frątczak A, Polak K, Miziołek B, Bergler-Czop B.   +7 more
europepmc   +1 more source

Real-World Persistence and Effectiveness of Upadacitinib versus Other Janus Kinase Inhibitors and Tumor Necrosis Factor Inhibitors in Australian Patients with Rheumatoid Arthritis [PDF]

Peter Youssef, Sabina Ciciriello, Talib Tahir, Joanna Leadbetter, Belinda Butcher, Miriam Calao, Nicole C. Walsh, Catherine O’Sullivan, Tegan Smith, Geoffrey Littlejohn   +9 more
openalex   +1 more source

Optimal use and cycling strategies of Janus kinase inhibitors in ulcerative colitis: current evidence and clinical implications from the KASID Guidelines Task Force Team. [PDF]

Intest Res
Hong SM, Kim DH, Bae JH, Shin SY, Song EM, Kim JE, Yang YJ, Yoon J, Kang SB, Kim ES, Kim SE, Kim SJ, Lee J, Na SY, Park SJ, Park SH, Choi M, Kim MH, Moon W, Jung SA.   +19 more
europepmc   +1 more source